Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Serina Therapeutics ( (SER) ) has issued an announcement.
Serina Therapeutics, Inc. is making headlines with the announcement that their Chief Development Officer, Randall Moreadith, M.D., Ph.D., will be participating in the prestigious 14th Annual Injectables Summit in Boston. This significant event will feature a presentation by Moreadith, highlighting the company’s latest advancements. Investors and those following the biotech sector should note that this participation underscores Serina Therapeutics’ commitment to innovation and development in the pharmaceutical field.
See more insights into SER stock on TipRanks’ Stock Analysis page.
